HomeNews

Zepto Partners with Orange Health for In-App Diagnostics Trial in Indian Cities: A Game-Changer for Healthcare Access

Alfred LeeAlfred Lee3h ago

Zepto Partners with Orange Health for In-App Diagnostics Trial in Indian Cities: A Game-Changer for Healthcare Access

Zepto, a leading quick-commerce platform in India, has teamed up with Orange Health Labs to launch a groundbreaking trial of in-app diagnostics services across select Indian cities.

This innovative collaboration allows users to book essential health tests, such as full-body checkups, directly through the Zepto app, with sample collection promised in under 60 minutes.

Revolutionizing Healthcare Accessibility in India

The partnership marks a significant step toward integrating healthcare with everyday convenience, addressing the growing demand for accessible diagnostics in urban India.

By leveraging Zepto’s robust delivery network and Orange Health’s expertise in rapid diagnostics, the trial aims to redefine how Indians approach routine health checkups.

A Brief History of Quick-Commerce and Healthcare Integration

Zepto, known for its 10-minute grocery deliveries, has been expanding its offerings, recently venturing into pharmacy services with Zepto Pharmacy in cities like Mumbai and Bengaluru.

Similarly, Orange Health Labs has carved a niche as one of India’s fastest diagnostic services, initially gaining prominence as Bengaluru’s largest COVID-19 testing lab during the pandemic.

Impact on Urban Healthcare Landscape

This trial could significantly impact urban healthcare by reducing the need for physical visits to diagnostic centers, saving time for busy professionals and families.

With India’s diagnostics market projected to reach $40 billion by 2034, as per industry estimates, such innovations could accelerate market growth and competition.

Challenges and Future Prospects

However, challenges remain, including ensuring accuracy, scalability, and regulatory compliance in a highly sensitive sector like healthcare diagnostics.

Looking ahead, a successful trial could pave the way for nationwide expansion, potentially integrating more advanced health services into platforms like Zepto.

Industry experts believe this could inspire other quick-commerce players to explore healthcare partnerships, further blurring the lines between e-commerce and health tech.

As Zepto and Orange Health refine this beta service, the future of at-home diagnostics in India looks promising, with potential to enhance healthcare equity across diverse demographics.

Article Details

Author / Journalist:

Category: StartupsTechnology

Markets:

Topics:

Source Website Secure: No (HTTP)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-11-20 @ 02:49:41 (3 hours ago)

News Timezone: GMT +8:00

News Source URL: beamstart.com

Language: English

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Tech In Asia

News ID: 30132603

About Tech In Asia

Tech In Asia Logo

Main Topics: StartupsTechnology

Official Website: techinasia.com

Update Frequency: 12 posts per day

Year Established: 2010

Headquarters: Singapore

Coverage Areas: Singapore

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #9

Frequently Asked Questions

Which news outlet covered this story?

The story "Zepto Partners with Orange Health for In-App Diagnostics Trial in Indian Cities: A Game-Changer for Healthcare Access" was covered 3 hours ago by Tech In Asia, a news publisher based in Singapore.

How trustworthy is 'Tech In Asia' news outlet?

Tech In Asia is a fully independent (privately-owned) news outlet established in 2010 that covers mostly startups and technology news.

The outlet is headquartered in Singapore and publishes an average of 12 news stories per day.

What do people currently think of this news story?

The sentiment for this story is currently Positive, indicating that people regard this as "good news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #30132603
  • URL: https://beamstart.com/news/zepto-orange-health-to-trial-17636075825887

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.